Spinal Cord Neuromodulation Therapy Study:

This study is testing a new therapy called SCONE to help people with bladder issues caused by problems in the nerves controlling the bladder, known as Neurogenic Lower Urinary Tract Dysfunction (NLUTD). The study will last 12 weeks and compares the SCONE therapy to a fake treatment to see if it helps improve symptoms like needing to urinate often or having accidents.

Eligibility: Adults aged 18 to 75 with certain conditions like spinal cord injury, multiple sclerosis, or stroke may join. You must have symptoms like frequent urination, and your health should be stable. Specific medical conditions or devices might make you ineligible.

Key Points:

• The study lasts for 12 weeks.
• Participants will receive either the SCONE therapy or a sham (inactive) treatment.
• You must not rely on certain medical devices or have specific surgeries to join.

If you meet the criteria and are interested in seeing if this therapy can help manage your bladder symptoms, consider participating.